Feed 002644.SZ
00
LanZhou Foci Pharmaceutical Co.,Ltd.
002644.SZ · SHZ
¥8.48 -3.64% (-¥0.32)
1M +9.69%
Market Cap ¥4.3B
P/E Ratio 82.50x
Div. Yield 0.24%
ROE 2.87%
Bulios Fair Price
¥4.38
48.3% downside
Current Price
¥8.48
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 002644.SZ is currently overvalued relative to its market price. How does it work?
Piotroski F-Score Moderate
5/9Valuation
32 /100
Expensive P/E 82.50x
EV/EBITDA 50.25x
P/S 4.77x
Growth
29 /100
Declining EPS growth 22.89%
Rev. growth 4.23%
FCF growth 75.00%
Profitability
60 /100
Moderate Gross margin 34.50%
Net margin 5.78%
Op. margin 6.62%
Quality
13 /100
Poor ROIC 2.00%
ROE 2.87%
ROA 2.05%
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 3.04x
Int. coverage 45.20x
Stability
71 /100
Stable Beta 0.26x
Rev. volatility 13.90%
EPS volatility 15.31%
Ask StockBot about 002644.SZ
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jinfeng Yue
Employees
1,332
Headquarters
Lanzhou